HEADER TRANSFERASE 22-FEB-23 8CN7 TITLE PA.FABF-C164Q IN COMPLEX WITH PLATENCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.3.1.179; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: FABF1, PA2965; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, TRANSFERASE, FABF, COMPLEX, PLATENCIN, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR C.GEORGIOU,R.BRENK REVDAT 1 10-JAN-24 8CN7 0 JRNL AUTH C.GEORGIOU,L.O.ESPELAND,H.BUKYA,V.YADRYKHINSKY,B.E.HAUG, JRNL AUTH 2 P.MAINKAR,R.BRENK JRNL TITL NEW STARTING POINTS FOR ANTIBIOTICS TARGETING P. AERUGINOSA JRNL TITL 2 FABF DISCOVERED BY CRYSTALLOGRAPHIC FRAGMENT SCREENING JRNL TITL 3 FOLLOWED BY HIT EXPANSION JRNL REF CHEMRXIV 2023 JRNL REFN ISSN 2573-2293 JRNL DOI 10.26434/CHEMRXIV-2023-CWK25 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 39885 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2101 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3023 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6074 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 166 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.41000 REMARK 3 B22 (A**2) : -0.59000 REMARK 3 B33 (A**2) : -1.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.31000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.253 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.672 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6447 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 6155 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8733 ; 1.480 ; 1.634 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14101 ; 1.324 ; 1.573 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 857 ; 7.390 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 327 ;33.565 ;20.581 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 998 ;14.650 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 58 ;18.116 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 826 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7469 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1511 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3339 ; 2.260 ; 3.257 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3338 ; 2.260 ; 3.256 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4183 ; 3.152 ; 4.877 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4184 ; 3.152 ; 4.878 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3108 ; 3.231 ; 3.790 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3109 ; 3.230 ; 3.790 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4536 ; 4.893 ; 5.493 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6996 ; 6.438 ;39.970 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6987 ; 6.432 ;39.937 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8CN7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1292128819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976250 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 64.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.42200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.20M AMMONIUM FORMATE AND 31.2% REMARK 280 PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.38950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 62 -43.98 -136.99 REMARK 500 ALA A 163 -129.96 55.96 REMARK 500 TRP A 223 -0.02 68.15 REMARK 500 SER A 264 141.22 -174.53 REMARK 500 PHE A 268 -71.65 -100.68 REMARK 500 SER A 307 19.27 81.90 REMARK 500 LEU A 343 -118.87 56.29 REMARK 500 HIS A 383 -43.06 78.23 REMARK 500 ALA B 163 -125.63 49.20 REMARK 500 ASP B 228 24.63 -140.40 REMARK 500 SER B 264 128.42 177.73 REMARK 500 PHE B 268 -62.65 -106.27 REMARK 500 SER B 307 20.96 87.40 REMARK 500 LEU B 343 -108.95 53.04 REMARK 500 CYS B 376 57.68 -91.65 REMARK 500 HIS B 383 -47.37 77.48 REMARK 500 PHE B 412 106.83 -160.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8CN5 RELATED DB: PDB REMARK 900 SAME PROTEIN DIFFERENT INHIBITOR DBREF 8CN7 A 2 413 UNP G3XDA2 G3XDA2_PSEAE 2 413 DBREF 8CN7 B 2 413 UNP G3XDA2 G3XDA2_PSEAE 2 413 SEQADV 8CN7 GLN A 164 UNP G3XDA2 CYS 164 ENGINEERED MUTATION SEQADV 8CN7 GLN B 164 UNP G3XDA2 CYS 164 ENGINEERED MUTATION SEQRES 1 A 412 SER ARG ARG ARG VAL VAL ILE THR GLY MET GLY MET LEU SEQRES 2 A 412 SER PRO LEU GLY LEU ASP VAL PRO SER SER TRP GLU GLY SEQRES 3 A 412 ILE LEU ALA GLY ARG SER GLY ILE ALA PRO ILE GLU HIS SEQRES 4 A 412 MET ASP LEU SER ALA TYR SER THR ARG PHE GLY GLY SER SEQRES 5 A 412 VAL LYS GLY PHE ASN VAL GLU GLU TYR LEU SER ALA LYS SEQRES 6 A 412 GLU ALA ARG LYS LEU ASP LEU PHE ILE GLN TYR GLY LEU SEQRES 7 A 412 ALA ALA SER PHE GLN ALA VAL ARG ASP SER GLY LEU GLU SEQRES 8 A 412 VAL THR ASP ALA ASN ARG GLU ARG ILE GLY VAL SER MET SEQRES 9 A 412 GLY SER GLY ILE GLY GLY LEU THR ASN ILE GLU ASN ASN SEQRES 10 A 412 CYS ARG SER LEU PHE GLU GLN GLY PRO ARG ARG ILE SER SEQRES 11 A 412 PRO PHE PHE VAL PRO GLY SER ILE ILE ASN MET VAL SER SEQRES 12 A 412 GLY PHE LEU SER ILE HIS LEU GLY LEU GLN GLY PRO ASN SEQRES 13 A 412 TYR ALA LEU THR THR ALA GLN THR THR GLY THR HIS SER SEQRES 14 A 412 ILE GLY MET ALA ALA ARG ASN ILE ALA TYR GLY GLU ALA SEQRES 15 A 412 ASP VAL MET VAL ALA GLY GLY SER GLU MET ALA ALA CYS SEQRES 16 A 412 GLY LEU GLY LEU GLY GLY PHE GLY ALA ALA ARG ALA LEU SEQRES 17 A 412 SER THR ARG ASN ASP GLU PRO THR ARG ALA SER ARG PRO SEQRES 18 A 412 TRP ASP ARG ASP ARG ASP GLY PHE VAL LEU SER ASP GLY SEQRES 19 A 412 SER GLY ALA LEU VAL LEU GLU GLU LEU GLU HIS ALA ARG SEQRES 20 A 412 ALA ARG GLY ALA ARG ILE TYR ALA GLU LEU VAL GLY PHE SEQRES 21 A 412 GLY MET SER GLY ASP ALA PHE HIS MET THR ALA PRO PRO SEQRES 22 A 412 GLU ASP GLY ALA GLY ALA ALA ARG CYS MET LYS ASN ALA SEQRES 23 A 412 LEU ARG ASP ALA GLY LEU ASP PRO ARG GLN VAL ASP TYR SEQRES 24 A 412 ILE ASN ALA HIS GLY THR SER THR PRO ALA GLY ASP ILE SEQRES 25 A 412 ALA GLU ILE ALA ALA VAL LYS SER VAL PHE GLY GLU HIS SEQRES 26 A 412 ALA HIS ALA LEU SER MET SER SER THR LYS SER MET THR SEQRES 27 A 412 GLY HIS LEU LEU GLY ALA ALA GLY ALA VAL GLU ALA ILE SEQRES 28 A 412 PHE SER VAL LEU ALA LEU ARG ASP GLN VAL ALA PRO PRO SEQRES 29 A 412 THR ILE ASN LEU ASP ASN PRO ASP GLU GLY CYS ASP LEU SEQRES 30 A 412 ASP LEU VAL ALA HIS GLU ALA LYS PRO ARG LYS ILE ASP SEQRES 31 A 412 VAL ALA LEU SER ASN SER PHE GLY PHE GLY GLY THR ASN SEQRES 32 A 412 GLY THR LEU VAL PHE ARG ARG PHE ALA SEQRES 1 B 412 SER ARG ARG ARG VAL VAL ILE THR GLY MET GLY MET LEU SEQRES 2 B 412 SER PRO LEU GLY LEU ASP VAL PRO SER SER TRP GLU GLY SEQRES 3 B 412 ILE LEU ALA GLY ARG SER GLY ILE ALA PRO ILE GLU HIS SEQRES 4 B 412 MET ASP LEU SER ALA TYR SER THR ARG PHE GLY GLY SER SEQRES 5 B 412 VAL LYS GLY PHE ASN VAL GLU GLU TYR LEU SER ALA LYS SEQRES 6 B 412 GLU ALA ARG LYS LEU ASP LEU PHE ILE GLN TYR GLY LEU SEQRES 7 B 412 ALA ALA SER PHE GLN ALA VAL ARG ASP SER GLY LEU GLU SEQRES 8 B 412 VAL THR ASP ALA ASN ARG GLU ARG ILE GLY VAL SER MET SEQRES 9 B 412 GLY SER GLY ILE GLY GLY LEU THR ASN ILE GLU ASN ASN SEQRES 10 B 412 CYS ARG SER LEU PHE GLU GLN GLY PRO ARG ARG ILE SER SEQRES 11 B 412 PRO PHE PHE VAL PRO GLY SER ILE ILE ASN MET VAL SER SEQRES 12 B 412 GLY PHE LEU SER ILE HIS LEU GLY LEU GLN GLY PRO ASN SEQRES 13 B 412 TYR ALA LEU THR THR ALA GLN THR THR GLY THR HIS SER SEQRES 14 B 412 ILE GLY MET ALA ALA ARG ASN ILE ALA TYR GLY GLU ALA SEQRES 15 B 412 ASP VAL MET VAL ALA GLY GLY SER GLU MET ALA ALA CYS SEQRES 16 B 412 GLY LEU GLY LEU GLY GLY PHE GLY ALA ALA ARG ALA LEU SEQRES 17 B 412 SER THR ARG ASN ASP GLU PRO THR ARG ALA SER ARG PRO SEQRES 18 B 412 TRP ASP ARG ASP ARG ASP GLY PHE VAL LEU SER ASP GLY SEQRES 19 B 412 SER GLY ALA LEU VAL LEU GLU GLU LEU GLU HIS ALA ARG SEQRES 20 B 412 ALA ARG GLY ALA ARG ILE TYR ALA GLU LEU VAL GLY PHE SEQRES 21 B 412 GLY MET SER GLY ASP ALA PHE HIS MET THR ALA PRO PRO SEQRES 22 B 412 GLU ASP GLY ALA GLY ALA ALA ARG CYS MET LYS ASN ALA SEQRES 23 B 412 LEU ARG ASP ALA GLY LEU ASP PRO ARG GLN VAL ASP TYR SEQRES 24 B 412 ILE ASN ALA HIS GLY THR SER THR PRO ALA GLY ASP ILE SEQRES 25 B 412 ALA GLU ILE ALA ALA VAL LYS SER VAL PHE GLY GLU HIS SEQRES 26 B 412 ALA HIS ALA LEU SER MET SER SER THR LYS SER MET THR SEQRES 27 B 412 GLY HIS LEU LEU GLY ALA ALA GLY ALA VAL GLU ALA ILE SEQRES 28 B 412 PHE SER VAL LEU ALA LEU ARG ASP GLN VAL ALA PRO PRO SEQRES 29 B 412 THR ILE ASN LEU ASP ASN PRO ASP GLU GLY CYS ASP LEU SEQRES 30 B 412 ASP LEU VAL ALA HIS GLU ALA LYS PRO ARG LYS ILE ASP SEQRES 31 B 412 VAL ALA LEU SER ASN SER PHE GLY PHE GLY GLY THR ASN SEQRES 32 B 412 GLY THR LEU VAL PHE ARG ARG PHE ALA HET DMS A 501 4 HET DMS A 502 4 HET DMS A 503 4 HET DMS A 504 4 HET DMS A 505 4 HET DMS A 506 4 HET DMS A 507 4 HET DMS A 508 4 HET DMS A 509 4 HET DMS A 510 4 HET DMS A 511 4 HET N32 A 512 31 HET DMS A 513 4 HET DMS A 514 4 HET DMS B 501 4 HET DMS B 502 4 HET DMS B 503 4 HET DMS B 504 4 HET DMS B 505 4 HET DMS B 506 4 HET DMS B 507 4 HET DMS B 508 4 HET DMS B 509 4 HET DMS B 510 4 HET DMS B 511 4 HET DMS B 512 4 HET DMS B 513 4 HET N32 B 514 31 HETNAM DMS DIMETHYL SULFOXIDE HETNAM N32 2,4-DIHYDROXY-3-({3-[(2S,4AS,8S,8AR)-8-METHYL-3- HETNAM 2 N32 METHYLIDENE-7-OXO-1,3,4,7,8,8A-HEXAHYDRO-2H-2,4A- HETNAM 3 N32 ETHANONAPHTHALEN-8-YL]PROPANOYL}AMINO)BENZOIC ACID HETSYN N32 PLATENCIN FORMUL 3 DMS 26(C2 H6 O S) FORMUL 14 N32 2(C24 H27 N O6) FORMUL 31 HOH *186(H2 O) HELIX 1 AA1 ASP A 20 GLY A 31 1 12 HELIX 2 AA2 ASN A 58 TYR A 62 5 5 HELIX 3 AA3 SER A 64 ARG A 69 1 6 HELIX 4 AA4 ASP A 72 GLY A 90 1 19 HELIX 5 AA5 ASN A 97 GLU A 99 5 3 HELIX 6 AA6 GLY A 111 GLN A 125 1 15 HELIX 7 AA7 GLY A 126 ILE A 130 5 5 HELIX 8 AA8 ASN A 141 GLY A 152 1 12 HELIX 9 AA9 THR A 162 GLN A 164 5 3 HELIX 10 AB1 THR A 165 TYR A 180 1 16 HELIX 11 AB2 CYS A 196 ALA A 206 1 11 HELIX 12 AB3 GLU A 215 SER A 220 1 6 HELIX 13 AB4 LEU A 244 ARG A 250 1 7 HELIX 14 AB5 GLY A 277 ALA A 291 1 15 HELIX 15 AB6 ASP A 294 VAL A 298 5 5 HELIX 16 AB7 THR A 308 GLY A 324 1 17 HELIX 17 AB8 GLU A 325 ALA A 329 5 5 HELIX 18 AB9 THR A 335 GLY A 340 1 6 HELIX 19 AC1 LEU A 342 GLY A 344 5 3 HELIX 20 AC2 ALA A 345 GLN A 361 1 17 HELIX 21 AC3 ASP B 20 GLY B 31 1 12 HELIX 22 AC4 ASN B 58 TYR B 62 5 5 HELIX 23 AC5 SER B 64 LYS B 70 1 7 HELIX 24 AC6 ASP B 72 GLY B 90 1 19 HELIX 25 AC7 ASN B 97 GLU B 99 5 3 HELIX 26 AC8 GLY B 111 GLY B 126 1 16 HELIX 27 AC9 PRO B 127 ILE B 130 5 4 HELIX 28 AD1 ASN B 141 GLY B 152 1 12 HELIX 29 AD2 THR B 162 GLN B 164 5 3 HELIX 30 AD3 THR B 165 TYR B 180 1 16 HELIX 31 AD4 CYS B 196 ALA B 206 1 11 HELIX 32 AD5 GLU B 215 SER B 220 1 6 HELIX 33 AD6 LEU B 244 ARG B 250 1 7 HELIX 34 AD7 GLY B 277 GLY B 292 1 16 HELIX 35 AD8 ASP B 294 VAL B 298 5 5 HELIX 36 AD9 THR B 308 GLY B 324 1 17 HELIX 37 AE1 GLU B 325 ALA B 329 5 5 HELIX 38 AE2 THR B 335 GLY B 340 1 6 HELIX 39 AE3 LEU B 342 GLY B 344 5 3 HELIX 40 AE4 ALA B 345 GLN B 361 1 17 SHEET 1 AA110 ASN A 157 TYR A 158 0 SHEET 2 AA110 ILE A 101 GLY A 106 1 N VAL A 103 O TYR A 158 SHEET 3 AA110 VAL A 185 GLU A 192 1 O VAL A 187 N SER A 104 SHEET 4 AA110 GLY A 235 GLU A 243 -1 O LEU A 241 N MET A 186 SHEET 5 AA110 VAL A 6 LEU A 14 -1 N GLY A 10 O VAL A 240 SHEET 6 AA110 ALA A 256 GLY A 265 -1 O LEU A 258 N VAL A 6 SHEET 7 AA110 THR A 403 ARG A 410 -1 O ARG A 410 N GLU A 257 SHEET 8 AA110 VAL A 392 GLY A 399 -1 N ALA A 393 O PHE A 409 SHEET 9 AA110 TYR A 300 ASN A 302 1 N ASN A 302 O LEU A 394 SHEET 10 AA110 SER A 331 SER A 333 1 O SER A 331 N ILE A 301 SHEET 1 AA2 2 ILE A 35 PRO A 37 0 SHEET 2 AA2 2 PHE A 50 GLY A 52 -1 O GLY A 51 N ALA A 36 SHEET 1 AA3 2 VAL A 362 ALA A 363 0 SHEET 2 AA3 2 LYS A 386 PRO A 387 -1 O LYS A 386 N ALA A 363 SHEET 1 AA410 ASN B 157 TYR B 158 0 SHEET 2 AA410 ILE B 101 GLY B 106 1 N VAL B 103 O TYR B 158 SHEET 3 AA410 VAL B 185 GLU B 192 1 O VAL B 187 N SER B 104 SHEET 4 AA410 GLY B 235 GLU B 243 -1 O LEU B 241 N MET B 186 SHEET 5 AA410 VAL B 6 LEU B 14 -1 N GLY B 10 O VAL B 240 SHEET 6 AA410 ALA B 256 MET B 263 -1 O ALA B 256 N ILE B 8 SHEET 7 AA410 THR B 403 ARG B 410 -1 O ARG B 410 N GLU B 257 SHEET 8 AA410 VAL B 392 GLY B 399 -1 N ALA B 393 O PHE B 409 SHEET 9 AA410 TYR B 300 ASN B 302 1 N ASN B 302 O LEU B 394 SHEET 10 AA410 SER B 331 SER B 333 1 O SER B 331 N ILE B 301 SHEET 1 AA5 2 ALA B 36 PRO B 37 0 SHEET 2 AA5 2 PHE B 50 GLY B 51 -1 O GLY B 51 N ALA B 36 SHEET 1 AA6 2 VAL B 362 ALA B 363 0 SHEET 2 AA6 2 LYS B 386 PRO B 387 -1 O LYS B 386 N ALA B 363 CRYST1 71.001 64.779 84.586 90.00 106.30 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014084 0.000000 0.004119 0.00000 SCALE2 0.000000 0.015437 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012317 0.00000